Abstract: The invention relates to an elevator car which is suitable for elevators in which all of the elements which are to be maintained and checked are arranged outside the elevator car, opposite only one side of the elevator car. The elevator car comprises, on said side, one part (3) that is arranged more than 85 cm above the elevator base (1) on the elevator wall (2) and that can be removed from inside the elevator. The part (3) is as least 95 cm in height and, after being removed, can rest vertically on the base of the elevator (1), against the elevator wall (2), in order to form a balustrade (4). At least one spacer (5,19) is arranged between the removable part (3) and the lower part (6) of the elevator wall (2) so that the distance from the inner side of the side wall part (3) that is placed on the base (1), facing the elevator, to the elements (7, 8) of the elevator drive moving past the travelling elevator car is at least 10 cm.

Abstract: The present invention relates to a device comprising a shaped shoulder piece to rest on the shoulders of a person to be treated, and a shaped head piece to be laid on it, as support for the chin and two bottom points of the rear lower edge of the skull. This ensures a three-point support of the head on the top side of this shaped head piece. Further, the device comprises a lifting mechanism, which is inserted between the back of the shaped shoulder piece and the shaped head piece. This lifting mechanism is simply a pump in the form of a bellows with a one-way valve for discharge, by which the air cushion can be inflated and discharged arbitrarily.

Abstract: Prefabricated insulation wall panels for construction of a concrete wall include two elongated studs, each having a planar web section and inner and outer flanges, and one or two insulation boards vertically disposed between the two studs. The web section includes multiple through-holes spaced apart in the body portion of the stud, disposed off center in a transverse direction and closer to the inner flange than to the outer flange. The insulation board is thinner than the width of the wed section. The inner surface of the insulation board is disposed against the inner flanges of the studs, with two side edges of the insulation board covering the through-holes on the web section of each stud, thus establishing a distance between the outer surface of the insulation board and the outer flanges of the studs through the body portion of the studs.

Abstract: A grill consisting of liquid-cooled grill plates and liquid-cooled lateral panels, the surfaces of which are provided with wear plates (1) connected to the liquid-cooled grill plates (2) and lateral planks in a heat-conducting manner. Wear plates (1) consist of a wear-resistant material which must however be cooled. Advantageously, a layer of a heat-conducting material in the form of a highly heat-conducting soft silicon film (3) is clamped between the liquid-cooled grill plates (2) and lateral panels and the wear plates (1), the layer providing a good heat transfer between the wear plates (1) and the permeable grill plates (2) and central panels. It is thus ensured that, during operation, the wear plates (1) always remain in a non-critical temperature range as they are cooled by the underlying grill plates (2) and lateral panels which are cooled to ca. 50° C.

Abstract: The present invention provides a security functional thin film and a security product containing such a thin film. The security functional thin film is of an amorphous structure, and possesses soft magnetic characteristics. Large Barkhausen effect can be detected along the in-plane preferred direction of magnetization; and the Large Barkhausen effect significantly attenuates, or no such signal can be detected, in a direction perpendicular to the in-plane preferred direction of magnetization. The thin film has a thickness of 20-300 nm, and the thin film also possesses element encoding characteristics that can be authenticated by experts. The security functional thin film of the present invention can be fabricated by magnetron sputtering web coating process.

Abstract: The invention relates to a device comprising a tubular circuit provided with at least one pump (9), a vacuum chamber (1) for processing the surfaces of parts placed therein, an actuation device (10), high voltage electrodes and a high frequency coil comprising a separate generator provided with a frequency converter for producing an electric field. The inventive device also comprises a transversal resonator for producing an aerosol and injection nozzles for spraying said aerosol into the vacuum chamber (1). The emulsion crosses the actuation device (10) in which electric and electromagnetic fields of 1-10000 volts, whose superimposed frequencies ranging from 10 Hz to 1 GHz are produced by a high-voltage electrode and the high frequency electromagnetic coil with the aid of the generator. By superimpose in the fields, a potential Zeta variation generates the transformation of a microemulsion into a nanoemulsion for processing part surfaces.

Abstract: Compositions, kits and methods are provided for promoting general health or for prevention or treatment of diseases by using novel recombinant fusion proteins of human serum albumin (HSA) and bioactive molecules. The bioactive molecules may be a protein or peptide having a biological function in vitro or in vivo, and preferably, having a therapeutic activity when administered to a human. By fusing the bioactive molecule to HSA, stability of the bioactive molecule in vivo can be improved and the therapeutic index increased due to reduced toxicity and longer-lasting therapeutic effects in vivo. In addition, manufacturing processes are provided for efficient, cost-effective production of these recombinant proteins in yeast.

Abstract: The agent basically consists of Saxolith, a crystalline marble-based filler, and Erkamar, a binder having adhesive properties. The agent preferably also contains dimethylethanolamine to improve the dissolution of resins and to stabilize the pH, as well as isopropanol as the diluent, Sipernat to improve the flow properties, Agitan as defoaming agent and coagulant, as well as Byk to improve the flow properties and as a filler. The agent is produced by adding Erkamar to at least the same quantity of water, mixing it and stirring it for a few hours, cooling the mixture to room temperature, and adding at least the same quantity of Saxolith as that of Erkamar added previously and stirring until a homogeneous mixture is obtained.

Abstract: The invention relates to a process for releasing at least one spring accumulator brake (10), which is operated by a pressure medium and which is connected to a brake-release-pressure-supply-circuit (63) in normal operation for impact with a brake release pressure and which, in service operation, is detached from the circuit (63) in case of failure of the brake release pressure and is released through a pressure medium source (37) against the spring force of the spring accumulator. To develop the process in such a way that the risk of an accident taking place reduces after the brake release pressure has failed, it has been proposed in the invention that at least one brake (10) gets re-connected automatically with the circuit (63) when the brake release pressure is provided again. Further, an apparatus and a hydraulic circuit for carrying out the process are proposed.

Abstract: The liquid-containing bag is produced integrally from two sheets (4; 5) which are welded to on another along the edge region (3), and the bag forms two chambers (6; 7) which are separated from one another by a separating strip (8). A drinking or dispensing spout (2) is welded with sealing action in the separating strip (8), in which case this connects the two chambers (6, 7) in the open state, the one bag chamber (6) being intended for receiving the liquid, while the other bag chamber (7), as a protective chamber, encompasses the outer spout end (9) and encloses the same with sealing action.

Abstract: A formaldehyde-free cleaner composition and method of use for maintaining a blood analyzer are disclosed. The cleaner composition includes surfactants, a proteolytic enzyme, non-formaldehyde releasing antimicrobials, alkaline metal salts, and a buffer. The cleaner composition has a pH in a range from about 7 to about 12 and a formaldehyde concentration equal or less than 1 ppm.

Abstract: A linearity control system includes a series of linearity control compositions, each thereof includes white blood cell analogs and stabilized red blood cells in a suspension medium. The concentration of the white blood cell analogs in the series of control compositions increases from 0.2×103 to 800×103 analogs per microliter, and the concentration of the white blood cell analogs in at least one control composition is greater than 120×103 analogs per microliter. The stabilized red blood cells facilitate mono-dispersion of the white blood cell analogs in the suspension medium by gently mixing. The control compositions further include platelet analogs, or additionally include reticulocyte and/or nucleated red blood cell analogs. The linearity control system allows the verification of the reportable measurement range and linearity of the measurements of hematology analyzers for white blood cells, red blood cells and platelets in extended concentration ranges.

Abstract: A multifunctional reagent for erythrocytes containing an amount sufficient to produce the lysis of erythrocytes or the sphering of erythrocytes in such a way that they can be detected by a cytometer or an automatic counting device, of a carbamate or of an agent inducing the formation by the erythrocytes, from carbonate and from a nitrogenated heterocycle or ammonium ions, of a carbamate combined with the absorption of CO2 by the erythrocytes, process for lysing or sphering erythrocytes and preparation process for leucocytes.

Abstract: A cell permeabilization and stabilization reagent and method of use are disclosed. The reagent contains a N-acyl sarcosine or a salt thereof, a pH adjusting agent to adjust pH of the reagent in a range from about 4 to about 6; and an aqueous medium; the reagent having a low ionic strength defined by a conductivity of less than 9.0 mS/cm. The reagent further contains bovine serum albumin and glycerol. The reagent may further include an alkyl sulfate surfactant. Upon incubating the cells with the reagent, the reagent permeates the cellular membrane to allow penetration of an intracellular marker, causes intracellular protein aggregation within the cellular membrane, while preserves a cellular constituent for binding with a cellular marker for subsequent analysis by flow cytometry.

Abstract: New diagnostic parameters or indexes for detection of absolute iron deficiency, latent iron deficiency, functional iron deficiency, or latent functional iron deficiency have been disclosed. The parameters include a RBC size factor, RSf1 defined by the formula of (MCV×MRV)1/2, or RSf2 defined by the formula of (MCV×MRV)/100, a volume-hemoglobin factor (VHf) defined by the formula of (MCV×Hgb)/100, and a volume-hemoglobin/distribution factor (VHDWf) defined by the formula of (MCV×Hgb)/(RDW×10). Further disclosed are the methods of using these parameters for detection of absolute iron deficiency, latent iron deficiency, functional iron deficiency, or latent functional iron deficiency. Also disclosed is a method of using RSf for detection of hemochromatosis.

Abstract: Methods for determining the responsiveness of a patient to recombinant human erythropoietin therapy are disclosed. In one approach, the method includes obtaining a volume-Hgb factor (VHf) defined as a product function of MCV and Hgb from a patient's blood sample; comparing VHf to a predetermined criterion; and reporting indication of responder if VHf meets the predetermined criterion. The method further includes using a RBC size-hemoglobin factor (RSHf) defined as a product function of MCV, MRV and Hgb, or using a function of VHf and RDW for determining the responsiveness. In another approach, the method includes using a RBC size factor (RSf) defined as a product function of MCV and MRV, in combination with transferrin saturation (TSAT) for determining the responsiveness to the erythropoietin therapy.

Abstract: A method of measuring cellular hemoglobin of a blood sample includes mixing a blood sample with a permeation reagent, and incubating the sample mixture to permeate cellular membrane of red blood cells and to cause hemoglobin aggregation within the cells; adding a neutralization reagent to inhibit further reactions of the permeation reagent; performing a cell-by-cell measurement of side scatter signals of the red blood cells in the sample mixture on a flow cytometer; and obtaining cellular hemoglobin (Hgbcell) of each red blood cell using the obtained side scatter signals. The method further includes measuring cellular hemoglobin of reticulocytes (Hgbretic) by differentiating reticulocytes using a simultaneous fluorescence measurement. The method also includes measuring cellular percentage of a hemoglobin variant in mature red blood cells or reticulocytes by adding a fluorescent antibody in the neutralization reagent and detecting fluorescence signals of antibody bound hemoglobin variant.

Abstract: Methods of prevention and correction of white blood cell interferences to the measurements of mean cell volume (MCV), red blood cell concentration (RBC) and hematocrit (Hct) of a blood sample are disclosed. The interference to MCV can be prevented by identifying a valley between the red blood cell and white blood cell modes on the red blood cell distribution histogram, defining a red blood cell region using the valley and calculating MCV within the defined region. Alternatively, a curve fit of the white blood cell population on the red blood cell distribution histogram can be used to exclude the white blood cells. RBC can be corrected by subtracting the white blood cell concentration obtained from the analysis of a second aliquot sample, when the white blood cell concentration (WBC) exceeds a predetermined criterion. Hct of the blood sample can be calculated using the obtained MCV and RBC.

Abstract: A method of using a reference control for measurement of immature granulocytes on a blood analyzer is disclosed. The method includes analyzing a reference control that contains an immature granulocyte component made of processed red blood cells for simulating immature granulocytes and a mature white blood cell component for simulating white blood cells of a blood sample on a blood analyzer adapted for measurement of immature granulocytes, and reporting the immature granulocyte component and the mature white blood cell component of the reference control.

Abstract: The present invention relates to a hematology instrument system that discriminates platelets from red blood cells, debris and other particles within a blood sample. The instrument system uses an optical trigger and collects data at optical sensor locations relative to a flow cell-illuminating laser beam's optical axis. An axial sensor measures axial light loss due to a particle in the flow cell's illumination aperture. In addition, the instrument system can include an RF unit generates electrical parameters, such as DC and RF parameters, within the flow cell. Blood specimens can be prepared with and without a sphering agent.